RecruitingNot ApplicableNCT06859970

An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure


Sponsor

InterShunt Technologies, Inc.

Enrollment

20 participants

Start Date

May 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this early feasibility study is to evaluate the safety and feasibility of the device for percutaneous shunting of the interatrial septum and improvement of heart failure related symptoms. The primary goal is to determine if the device is safe to use. The findings from this study may be used to refine the intended patient population, the design of the device, or develop a subsequent randomized study.


Eligibility

Min Age: 40 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This early feasibility study is testing a new device that creates a small opening between the heart's upper chambers (without leaving a permanent implant) to reduce fluid backup and pressure in patients with heart failure, potentially improving symptoms and reducing hospitalizations. **You may be eligible if...** - You have heart failure with reduced ejection fraction (heart pumps at 20–40% capacity) - You are in NYHA Class II–IV (moderate to severe heart failure symptoms) - You have had at least one hospitalization for heart failure, IV diuretics, or elevated BNP in the past year - You are already on maximum tolerated standard heart failure medications - Heart catheterization shows elevated filling pressures in the heart **You may NOT be eligible if...** - You have had a stroke, blood clot, or severe heart failure (non-ambulatory Class IV) in the past 6 months - You had a heart attack, cardiac surgery, or a cardiac device implanted in the past 3 months - Your heart is severely enlarged (LVEDD greater than 8 cm) or your cardiac output is very low - You are on a heart transplant list or have received inotropic drugs recently Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPAS-C System

All patients will undergo catheterization with the PAS-C System to create an interatrial shunt to reduce left atrial pressure in the heart.


Locations(6)

St. Bernard's Healthcare

Jonesboro, Arkansas, United States

Los Robles Health System

Thousand Oaks, California, United States

Ascension St. Vincent Hospital

Indianapolis, Indiana, United States

Christ Hospital

Cincinnati, Ohio, United States

The Ohio State University

Columbus, Ohio, United States

Methodist Healthcare

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06859970


Related Trials